Clinical observation of compound xiatianwu tablets in treatment of 120 cases with active rheumatoid arthritis / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 899-901, 2013.
Article
in Zh
| WPRIM
| ID: wpr-318620
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To observe the clinical efficacy of Compound Xiatianwu tablets in the treatment of active rheumatoid arthritis.</p><p><b>METHOD</b>One hundred and eighty cases with active rheumatoid arthritis were randomly divided into the control group (60 cases) with leflunomide, sulfasalazine, and celecoxib; the treatment group (120 cases) given compound Xiatianwu tablets on the basis of the control group, 2 tablets each time, 3 times/day, with the course of treatment of 3 month. Patients of the two groups were observed for clinical symptoms, erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor, and immunoglobulin changes before and after the treatment.</p><p><b>RESULT</b>The treatment group showed an overall efficiency of 94. 2% , the Xiatianwu group showed an overall efficiency of 80. 0%, while the control group showed an overall efficiency of 81.7%. The difference among the three groups was statistically significant (P <0. 05 or P <0. 01) , indicating that the treatment group was superior to the Xiatianwu group, while the Xiatianwu group was superior to the control group.</p><p><b>CONCLUSION</b>Compound Xiatianwu tablets has remarkable effect in the treatment of active rheumatoid arthritis.</p>
Full text:
1
Index:
WPRIM
Main subject:
Pathology
/
Pharmacology
/
Arthritis, Rheumatoid
/
Tablets
/
C-Reactive Protein
/
Immunoglobulins
/
Drugs, Chinese Herbal
/
Treatment Outcome
/
Therapeutic Uses
/
Drug Therapy
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
Zh
Journal:
China Journal of Chinese Materia Medica
Year:
2013
Type:
Article